Home
| Log in or Sign Up for full access
| Tracked Organizations
| Recent Tracked Activities
Recent Activities
Activities between Nov. 15, 2024, 7:55 p.m. and Nov. 22, 2024, 7:55 p.m.
from: Contract Manufacturing Services.
Click on a document link to see the original source document.
Click on the name of an organization to see more organization linkages and timelines.
Document Date: Nov. 20, 2024, 7:02 p.m. / Source: Fierce Pharma
Activity Class: PartnershipActivity
Partnership:
- UCB
/ Industry: Biopharmaceutical And Biotech Industry, Biotech And Technology and 6 more
- Samsung Biologics
/ Industry: Biopharmaceutical And Biotech Industry, Biotech And Technology and 7 more
- Samsung Biologics
/ Industry: Biopharmaceutical And Biotech Industry, Biotech And Technology and 7 more
- UCB
/ Industry: Biopharmaceutical And Biotech Industry, Biotech And Technology and 6 more
Document Extract: Back in July, the CDMO announced a $ 1.05 billion manufacturing partnership with an unnamed U.S. drugmaker set to run through 2030. The company followed up that reveal with news of a $ 1.2 billion contract with another anonymous, Asia - based pharmaceutical company in October. The latter deal is set to last through December 2037. Prior to those agreements, Samsung Bio expanded a long-running partnership with Belgium's UCB to manufacture an anti-tau candidate in progressive supranuclear palsy and retooled a deal with Baxter Healthcare to provide unspecified production services through 2034. While many other CDMOs have struggled to come to grips with the post-pandemic contracting industry, Samsung Bio has largely avoided headwinds since rising to prominence several years ago.
Document Source: https://www.fiercepharma.com/pharma/samsung-bio-inks-production-tie-another-unnamed-pharma-time-worth-668m
(archive.org page /
archive.org listing)
Document Date: Nov. 20, 2024, 7:02 p.m. / Source: Fierce Pharma
Activity Class: PartnershipActivity
Partnership:
- CDMO
/ Industry: Alternative Medicine And Natural Nutraceutical Products, Biopharmaceutical And Biotech Industry and 4 more
- Samsung Biologics
/ Industry: Biopharmaceutical And Biotech Industry, Biotech And Technology and 7 more
- CDMO
/ Industry: Alternative Medicine And Natural Nutraceutical Products, Biopharmaceutical And Biotech Industry and 3 more
- Samsung Biologics
/ Industry: Biopharmaceutical And Biotech Industry, Biotech And Technology and 7 more
Document Extract: Rather than commenting on the latest production tie-up directly, the company's CEO, John Rim, pledged in a statement to continue pouring the proceeds from Samsung Bio's contracting projects back into the CDMO's production capabilities. Following a slate of high-value deals this year, Samsung Biologics is now partnered with 17 of the world's top 20 pharmaceutical companies, the manufacturer said in a release. Next up, the CDMO is adding antibody-drug conjugate services, including process development and conjugation, to its portfolio of offerings, Samsung Bio said. Samsung Biologics has been in the habit of disclosing high-dollar contracts with unnamed customers in recent months. Back in July, the CDMO announced a $ 1.05 billion manufacturing partnership with an unnamed U.S. drugmaker set to run through 2030.
Document Source: https://www.fiercepharma.com/pharma/samsung-bio-inks-production-tie-another-unnamed-pharma-time-worth-668m
(archive.org page /
archive.org listing)
Document Date: Nov. 20, 2024, 7:02 p.m. / Source: Fierce Pharma
Activity Class: PartnershipActivity
Partnership:
- Samsung Biologics
/ Industry: Biopharmaceutical And Biotech Industry, Biotech And Technology and 7 more
- UCB
/ Industry: Biopharmaceutical And Biotech Industry, Biotech And Technology and 6 more
- Baxter Healthcare
- UCB
/ Industry: Biopharmaceutical And Biotech Industry, Biotech And Technology and 6 more
- Samsung Biologics
/ Industry: Biopharmaceutical And Biotech Industry, Biotech And Technology and 7 more
Document Extract: Samsung Biologics has been in the habit of disclosing high-dollar contracts with unnamed customers in recent months. Back in July, the CDMO announced a $ 1.05 billion manufacturing partnership with an unnamed U.S. drugmaker set to run through 2030. The company followed up that reveal with news of a $ 1.2 billion contract with another anonymous, Asia - based pharmaceutical company in October. The latter deal is set to last through December 2037. Prior to those agreements, Samsung Bio expanded a long-running partnership with Belgium's UCB to manufacture an anti-tau candidate in progressive supranuclear palsy and retooled a deal with Baxter Healthcare to provide unspecified production services through 2034.
Document Source: https://www.fiercepharma.com/pharma/samsung-bio-inks-production-tie-another-unnamed-pharma-time-worth-668m
(archive.org page /
archive.org listing)
Document Date: Nov. 18, 2024, 4:45 p.m. / Source: Fierce Network
Activity Class: CorporateFinanceActivity
/ Type: Acquisition
Buyer:
- Jabil
/ Industry: Construction Machinery And Heavy Equipment, Contract Manufacturing Services and 3 more
Document Extract: Now, it's putting the pedal to the metal, announcing a deal to be acquired by big-name contract manufacturer Jabil to massively scale its operations.
Document Source: https://www.fierce-network.com/cloud/cooling-tech-made-space-heads-data-centers-mikros-ceo-says
(archive.org page /
archive.org listing)
Document Date: Nov. 19, 2024, 10:27 a.m. / Source: GlobeNewswire
Activity Class: LocationActivity
/ Type: Added
Location_Added_By:
- Ardena
/ Industry: Contract Manufacturing Services, Pharma And Healthcare
- Ardena
/ Industry: Contract Manufacturing Services, Pharma And Healthcare
Location:
Document Extract: OSS, The Netherlands, Nov. 19, 2024 (GLOBE NEWSWIRE) - Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organisation (CDMO) with GMP facilities in Belgium, Spain, the Netherlands, and Sweden, announces the full Good Manufacturing Practice (GMP) approval of its expanded nanomedicine facility in Oss.
Document Source: https://www.globenewswire.com/news-release/2024/11/19/2983367/0/en/Ardena-s-New-State-of-the-Art-Nanomedicine-Facility-Secures-Full-GMP-Approval-for-Manufacturing.html
(archive.org page /
archive.org listing)
Document Date: Nov. 18, 2024, 2:15 p.m. / Source: PR Newswire
Activity Class: PartnershipActivity
/ Region: People’s Republic of China
Partnership:
Document Extract: The new entity formed in respect of the Joint Venture, Fujian Shengfeng Fulai Low Altitude Comprehensive Services Co., Ltd., is expected to leverage Shengfeng Logistics's expertise in logistics with Fulai Aviation's drone technology to deliver drone - based logistics solutions across China's low-altitude logistics sector. Shengfeng Logistics holds a majority stake in the 51 % in the Joint Venture, which is anticipated to affirm the Company's commitment to establishing a leadership role in this burgeoning field. The focus of the Joint Venture will be on providing tailored drone logistics services to address critical needs in remote and mountainous areas and island regions of Fujian Province. Additionally, Shengfeng anticipates that, through the Joint Venture, it may collaborate with local governments to support forest fire prevention and monitoring through drone patrols, to provide timely and effective response capabilities in environmental protection. Strategic Expansion in China's Low-Altitude Economy.
Document Source: https://www.prnewswire.com/news-releases/shengfeng-development-limited-announces-joint-venture-with-fujian-fulai-aviation-to-expand-low-altitude-logistics-services-302307616.html
(archive.org page /
archive.org listing)
Document Date: Nov. 18, 2024, 2:15 p.m. / Source: PR Newswire
Activity Class: PartnershipActivity
/ Region: People’s Republic of China
Partnership:
Document Extract: Shengfeng Development Limited Announces Joint Venture with Fujian Fulai Aviation to Expand Low-Altitude Logistics Services. FUZHOU, China, Nov. 18, 2024 /PRNewswire/ - Shengfeng Development Limited ("Shengfeng" or the "Company") (NASDAQ: SFWL) , a contract logistics company in China providing customers with integrated logistics solutions, announced today that on November 5, 2024, Shengfeng Logistics Group, a variable interest entity that the Company controls via a series of contractual arrangements ("Shengfeng Logistics") , forms a joint venture (the "Joint Venture") with Fujian Fulai Aviation Technology Co., Ltd. ("Fulai Aviation") . The new entity formed in respect of the Joint Venture, Fujian Shengfeng Fulai Low Altitude Comprehensive Services Co., Ltd., is expected to leverage Shengfeng Logistics's expertise in logistics with Fulai Aviation's drone technology to deliver drone - based logistics solutions across China's low-altitude logistics sector. Shengfeng Logistics holds a majority stake in the 51 % in the Joint Venture, which is anticipated to affirm the Company's commitment to establishing a leadership role in this burgeoning field. The focus of the Joint Venture will be on providing tailored drone logistics services to address critical needs in remote and mountainous areas and island regions of Fujian Province.
Document Source: https://www.prnewswire.com/news-releases/shengfeng-development-limited-announces-joint-venture-with-fujian-fulai-aviation-to-expand-low-altitude-logistics-services-302307616.html
(archive.org page /
archive.org listing)
Document Date: Nov. 18, 2024, 2:15 p.m. / Source: PR Newswire
Activity Class: PartnershipActivity
/ Region: People’s Republic of China
Partnership:
Document Extract: Shengfeng Development Limited Announces Joint Venture with Fujian Fulai Aviation to Expand Low-Altitude Logistics Services. FUZHOU, China, Nov. 18, 2024 /PRNewswire/ - Shengfeng Development Limited ("Shengfeng" or the "Company") (NASDAQ: SFWL) , a contract logistics company in China providing customers with integrated logistics solutions, announced today that on November 5, 2024, Shengfeng Logistics Group, a variable interest entity that the Company controls via a series of contractual arrangements ("Shengfeng Logistics") , forms a joint venture (the "Joint Venture") with Fujian Fulai Aviation Technology Co., Ltd. ("Fulai Aviation") . The new entity formed in respect of the Joint Venture, Fujian Shengfeng Fulai Low Altitude Comprehensive Services Co., Ltd., is expected to leverage Shengfeng Logistics's expertise in logistics with Fulai Aviation's drone technology to deliver drone - based logistics solutions across China's low-altitude logistics sector. Shengfeng Logistics holds a majority stake in the 51 % in the Joint Venture, which is anticipated to affirm the Company's commitment to establishing a leadership role in this burgeoning field. The focus of the Joint Venture will be on providing tailored drone logistics services to address critical needs in remote and mountainous areas and island regions of Fujian Province.
Document Source: https://www.prnewswire.com/news-releases/shengfeng-development-limited-announces-joint-venture-with-fujian-fulai-aviation-to-expand-low-altitude-logistics-services-302307616.html
(archive.org page /
archive.org listing)
Document Date: Nov. 20, 2024, 1 p.m. / Source: PR Newswire
Activity Class: PartnershipActivity
Partnership:
Document Extract: Dale Clendon, CEO of the Marena Group, said, "This exciting partnership represents our ongoing commitment to enhance the recovery experience of patients by offering unique products that feature the convergence of textiles and natural, active ingredients infused into the fabric. We have always been patient-centric, and we remain focused on exploring innovative ways to improve patients' post-operative experience through highly differentiated products ." " This exclusive global alliance with Clothing 2.0 enables Marena to safely deliver active, natural ingredients to the body via skin contact in our high-quality Marena Recovery garments. Marena has been known as the innovators in the space, and this revolutionary technology enables us to leap into the future" added Colin Marafko, Chief Commercial Officer at Marena. " We could n't be more excited about this partnership.
Document Source: https://www.prnewswire.com/news-releases/announcing-the-worlds-first-post-surgical-compression-garments-with-infused-pain-relief-ingredients-302310306.html
(archive.org page /
archive.org listing)
Document Date: Nov. 20, 2024, 1 p.m. / Source: PR Newswire
Activity Class: PartnershipActivity
/ Region: Earth
Partnership:
Document Extract: The Marena Group and Clothing 2.0 Partner to Transform Patients' Post-Surgical Recovery after Invasive and Non-Invasive Plastic and Body Sculpting Procedures. LAWRENCEVILLE, Ga. and CONOVER, N.C., Nov. 20, 2024 /PRNewswire/ - Clothing 2.0, the only company in the world that delivers doses of a natural, pain-relieving active ingredient through clothing, and The Marena Group LLC, the leading provider of medical-grade post-surgical compression garments, announce their alliance to bring groundbreaking innovation to assist patients undergoing invasive and minimally-invasive aesthetic and plastic surgery procedures. This partnership creates the world's first line of post-surgical garments infused with consistent over-the-counter pain-relieving active ingredients. They give clinicians and patients enhanced control of the post-surgical recovery process simply by wearing them. The garments are reusable and laundry-safe.
Document Source: https://www.prnewswire.com/news-releases/announcing-the-worlds-first-post-surgical-compression-garments-with-infused-pain-relief-ingredients-302310306.html
(archive.org page /
archive.org listing)
Document Date: Nov. 19, 2024, 1 p.m. / Source: PR Newswire
Activity Class: PartnershipActivity
Partnership:
Document Extract: MOEA "Big A+" program to accelerate AI innovation in medicine. TAIPEI, Nov. 19, 2024 /PRNewswire/ - Hon Hai Technology Group ("Foxconn") (TWSE:2317) , in partnership with two Taiwanese hospitals, has been selected for the Taiwan government-backed "Big A+" program that will give the world's largest electronics manufacturing service provider access to one of the world's most powerful supercomputers to accelerate AI-applied innovations for medicine. Foxconn teams up with Taichung Veterans General Hospital and Cardinal Tien Hospital for the "Pioneers for Innovation Leadership on Technology Program", referred to as the Big A+ program, a Ministry of Economic Affairs initiative. The selection means Foxconn and its partner hospitals will be able to access the NVIDIA Taipei-1 supercomputer and are the only candidates so far approved to use its accelerated computing power. Barry Chiang, Foxconn's head of digital health, said: "We are very honored to be selected into the Big A+ program.
Document Source: https://www.prnewswire.com/news-releases/hon-hai-technology-group-foxconn-teams-with-2-taiwan-hospitals-to-use-nvidia-enabled-taipei-1-supercomputer-302309961.html
(archive.org page /
archive.org listing)
Document Date: Nov. 19, 2024, 1 p.m. / Source: PR Newswire
Activity Class: PartnershipActivity
/ Region: Taiwan
Partnership:
Document Extract: TAIPEI, Nov. 19, 2024 /PRNewswire/ - Hon Hai Technology Group ("Foxconn") (TWSE:2317) , in partnership with two Taiwanese hospitals, has been selected for the Taiwan government-backed "Big A+" program that will give the world's largest electronics manufacturing service provider access to one of the world's most powerful supercomputers to accelerate AI-applied innovations for medicine. Foxconn teams up with Taichung Veterans General Hospital and Cardinal Tien Hospital for the "Pioneers for Innovation Leadership on Technology Program", referred to as the Big A+ program, a Ministry of Economic Affairs initiative. The selection means Foxconn and its partner hospitals will be able to access the NVIDIA Taipei-1 supercomputer and are the only candidates so far approved to use its accelerated computing power. Barry Chiang, Foxconn's head of digital health, said: "We are very honored to be selected into the Big A+ program. Foxconn will promote the development of smart medical care by leveraging the powerful computing power of NVIDIA Taipei-1.
Document Source: https://www.prnewswire.com/news-releases/hon-hai-technology-group-foxconn-teams-with-2-taiwan-hospitals-to-use-nvidia-enabled-taipei-1-supercomputer-302309961.html
(archive.org page /
archive.org listing)
Document Date: Nov. 19, 2024, 1 p.m. / Source: PR Newswire
Activity Class: PartnershipActivity
/ Region: Taiwan
Partnership:
Document Extract: Foxconn teams up with Taichung Veterans General Hospital and Cardinal Tien Hospital for the "Pioneers for Innovation Leadership on Technology Program", referred to as the Big A+ program, a Ministry of Economic Affairs initiative. The selection means Foxconn and its partner hospitals will be able to access the NVIDIA Taipei-1 supercomputer and are the only candidates so far approved to use its accelerated computing power. Barry Chiang, Foxconn's head of digital health, said: "We are very honored to be selected into the Big A+ program. Foxconn will promote the development of smart medical care by leveraging the powerful computing power of NVIDIA Taipei-1. We are working with partners to promote the digital transformation of the global industry and become a best practice representative of the deep integration of technology and medical care ."
Document Source: https://www.prnewswire.com/news-releases/hon-hai-technology-group-foxconn-teams-with-2-taiwan-hospitals-to-use-nvidia-enabled-taipei-1-supercomputer-302309961.html
(archive.org page /
archive.org listing)
Document Date: Nov. 21, 2024, 2:11 p.m. / Source: Business Wire
Activity Class: RoleActivity
/ Type: Starting
Role:
Person:
Organization:
- Vetter
/ Industry: Contract Manufacturing Services
- Vetter
/ Industry: Contract Manufacturing Services
Document Extract: Vetter, a globally operating Contract Development and Manufacturing Organization (CDMO) , has announced the appointment of three senior leaders to take on the role of managing directors alongside Thomas Otto and Peter Soelkner.
Document Source: https://www.businesswire.com/news/home/20241121031406/en/Vetter-Strengthens-Senior-Management-Team-for-Further-Sustainable-Growth
(archive.org page /
archive.org listing)
Document Date: Nov. 21, 2024, 2:11 p.m. / Source: Business Wire
Activity Class: RoleActivity
/ Type: Starting
Role:
Person:
Organization:
- Vetter
/ Industry: Contract Manufacturing Services
- Vetter
/ Industry: Contract Manufacturing Services
Document Extract: Vetter, a globally operating Contract Development and Manufacturing Organization (CDMO) , has announced the appointment of three senior leaders to take on the role of managing directors alongside Thomas Otto and Peter Soelkner.
Document Source: https://www.businesswire.com/news/home/20241121031406/en/Vetter-Strengthens-Senior-Management-Team-for-Further-Sustainable-Growth
(archive.org page /
archive.org listing)
Document Date: Nov. 21, 2024, 2:11 p.m. / Source: Business Wire
Activity Class: RoleActivity
/ Type: Starting
Role:
Person:
Organization:
- Vetter
/ Industry: Contract Manufacturing Services
- Vetter
/ Industry: Contract Manufacturing Services
Document Extract: Vetter, a globally operating Contract Development and Manufacturing Organization (CDMO) , has announced the appointment of three senior leaders to take on the role of managing directors alongside Thomas Otto and Peter Soelkner.
Document Source: https://www.businesswire.com/news/home/20241121031406/en/Vetter-Strengthens-Senior-Management-Team-for-Further-Sustainable-Growth
(archive.org page /
archive.org listing)
Document Date: Nov. 21, 2024, 2:11 p.m. / Source: Business Wire
Activity Class: RoleActivity
/ Type: Starting
Role:
Person:
Organization:
- Vetter
/ Industry: Contract Manufacturing Services
- Vetter
/ Industry: Contract Manufacturing Services
Document Extract: Vetter, a globally operating Contract Development and Manufacturing Organization (CDMO) , has announced the appointment of three senior leaders to take on the role of managing directors alongside Thomas Otto and Peter Soelkner.
Document Source: https://www.businesswire.com/news/home/20241121031406/en/Vetter-Strengthens-Senior-Management-Team-for-Further-Sustainable-Growth
(archive.org page /
archive.org listing)
Document Date: Nov. 21, 2024, 2:11 p.m. / Source: Business Wire
Activity Class: RoleActivity
/ Type: Starting
Role:
Person:
Organization:
- Vetter
/ Industry: Contract Manufacturing Services
- Vetter
/ Industry: Contract Manufacturing Services
Document Extract: Vetter, a globally operating Contract Development and Manufacturing Organization (CDMO) , has announced the appointment of three senior leaders to take on the role of managing directors alongside Thomas Otto and Peter Soelkner.
Document Source: https://www.businesswire.com/news/home/20241121031406/en/Vetter-Strengthens-Senior-Management-Team-for-Further-Sustainable-Growth
(archive.org page /
archive.org listing)
Archive.org page links will work if the page has already been archived by archive.org, but we can't guarantee which pages archive.org has archived so far.
Treat sameAsNameOnly relationship as same? Yes
(Turn Off)
Site Stats
| About (includes privacy and cookie notices)
(c) by 1145, 2023-2024. Data licensed under the Open Database License.
Please send an email if you need a non-share-alike license and/or you need API access.